Entasistx
1 known investors
Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.
Investors Β· 1
Frequently asked questions
- What does Entasistx do?
- Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.
- Who are Entasistx's investors?
- Entasistx's investors include Sofinnova Ventures.